Chandtip Chandhasin

Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors

Razelle Kurzrock, N. Gabrail, Chandtip Chandhasin et al. · Molecular Cancer Therapeutics · 2011 · 174 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer

Aung Naing, Razelle Kurzrock, Angelika M. Burger et al. · Clinical Cancer Research · 2011 · 116 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer

Emmanuel S. Antonarakis, Chandtip Chandhasin, Erica Osbourne et al. · The Oncologist · 2016 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

Prevalence of complementary medicine use in a phase 1 clinical trials program

Aung Naing, Saneese K. Stephen, Moshe Frenkel et al. · Cancer · 2011 · 56 citations · Full text

Medicine, Oncology, Cancer Drug Toxicity Management +8

Human T-Cell Leukemia Virus Type 1 Tax Attenuates the ATM-Mediated Cellular DNA Damage Response

Chandtip Chandhasin, Razvan I. Ducu, Elijahu Berkovich et al. · Journal of Virology · 2008 · 52 citations · Full text

Life Sciences, Molecular Biology, Oncology +17